Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition.

J Immunother Cancer · 2019 · PMC6814994 · PMID 31653272

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Tumors harvested from JQ1 treated mice showed a trend towards decreased PD-L1 expression (Fig. 3 c).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.